Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SEAOF $$SHORT$SQUEEZE$ COMING$$$. IMO
https://www.otcshortreport.com/company/SEAOF
$MGON Share Structure updated today!
Market Cap 1,735,441
11/14/2018 Authorized Shares 200,000,000
11/14/2018 Outstanding Shares 196,095,060
11/14/2018 Restricted 22,527
11/14/2018 Unrestricted 196,072,533
11/14/2018 Held at DTC 153,557,217
11/14/2018 Float 88,604,553
what up wit it?
$MGON looking primed for the coming week!
Arrayit (ARYC) sales and marketing team schedules shareholder company tours to showcase our impressive biomedical technology in private VIP tutorials arrayit.com/index.html
*********************
New investors in Silicon Valley biotech (trading at just over 6 pennies per share) Arrayit Corporation (ARYC):
@Arrayit on Twitter
Please do your due diligence on this Silicon Valley biotech company and you will see what an extremely undervalued company this is. It is finally getting the attention it deserves
http://www.arrayit.com/
Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
http://stockcharts.com/h-sc/ui?s=Aryc
A list of Arrayit Corporation patents:
https://t.co/EMXlE743rz
Here's a few recent updates from their website. For more links @ Arrayit and $ARYC on Twitter.
Please follow ARYC on Facebook for more updates :)
Arrayit microarray technology platform customers featured widely in Wells Fargo report by top analyst Tim Evans arrayit.com/confidential/l…
Arrayit advances OEM relationship with global medical technology and supply leaders GE Healthcare Chicago IL www3.gehealthcare.com/en
Arrayit featured with market leaders Illumina, Fluidigm and Affymetrix by world business insights leader Owler owler.com
Arrayit reports numerous emails to advance audit completion with top public company accounting firm RRBB Somerset NJ rrbb.com
Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $190,000 microarray services sale to a top research laboratory located in the Southern United States
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
?@arrayit?
Arrayit reports Parkinson's Disease Test PDx™ partnering opportunity with top physician in Molecular Medicine India
(link: http://nimhans.ac.in)
nimhans.ac.in
Arrayit reports $35,000 microarray services sale to a leading research laboratory specializing in complex pathways
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $168,000 microarray platform sale to leading medical suppliers Medi Laser located in Lahore Pakistan (link: http://www.medilaser.com.pk) medilaser.com.pk
Arrayit reports $100,000+ microarray services sale to a leading US-based research laboratory (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi…
Arrayit provides additional samples for $2.9 million microarray tech sale to United States Department of Defense DOD
http://www.
defense.gov
Arrayit microarray platform used by customers at University Medicine Bethesda MD to publish cancer research advance
www.twitter.com/arrayit
Arrayit schedules business development meeting today with top Vietnamese biotech firm regarding $10MM+ potential microarray growth account.
Arrayit customers in Toronto Canada use Arrayit microarray technology to publish advance on heart transplantation
http://
journals.plos.org/plosone/articl
e?id=10.1371/journal.pone.0151224
…
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit reports record blood card sales in Q3-16 on microarray immunoassay research apps http://www.arrayit.com/Produc
Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance
http://
onlinelibrary.wiley.com/doi/10.1111/xe
n.12260/full
…
Arrayit quotes $160,000 microarray platform to molecular diagnostic leader Akonni Biosystems http://www.akonni.com
Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia
?http://www.?
?chembio.ru?
Arrayit reports $34,500 SpotBot 4 Microarray platform sale, leading European Distributor Grupo Taper Sintra Portugal http://www.arrayit.com/Products/Microarrayers/Microarrayer/microarrayer.html …
Arrayit reports microarray sale to testing leader RDL Reference Laboratory Los Angeles CA http://www.rdlinc.com
Arrayit ships $40,000 microarray platform life sciences leader Daemyung Sciences Seoul Korea http://www.dm4you.com
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance
http://www.
sciencedirect.com/science/articl
e/pii/S1873506115000598
…
Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?...
?http://?
?fb.me/2Xx9b1Oom?
Arrayit reports $30,000 microarray services sale to a top research
Arrayit quotes $179,430 microarrays to biomedical leader Progenie Molecular Valencia España http://www.progenie-molecular.com
Arrayit quotes $51,680 microarrays to top leader De La Salle University Manila Philippines http://www.dlsu.edu.ph
Arrayit quotes $102,240 microarray platform to venture think tank Leading Technology Group http://www.leadingtechnology.co
Arrayit Corporation ?@arrayit
Arrayit completes conference call on huge DNA testing opportunity in massive market in India http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html …
Arrayit reports DNA testing inquiry from top agency in India. Market penetration of 0.1% would produce $48M revenues http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html …
Arrayit Corporation ?@arrayit
Arrayit quotes $235,000 microarray instruments to top lab University Ottawa Ontario Canada http://www.uottawa.ca
Arrayit reports microarray sale to advanced technology leaders Waki Company Tokyo Japan http://waki-bg.jp
Arrayit reports microarray sale to automated molecular testing leader AutoGenomics Vista CA http://www.autogenomics.com
Arrayit reports microarray sale to life sciences European Biotech Network Dolembreux Belgium http://www.euro-bio-net.com
Arrayit reports microarray sale to top medical researcher at $13.4B endowed MIT Cambridge MA http://web.mit.edu
Arrayit expands marketing on $100K TissueMax™ Automated and Personal Tissue Microarrayers sale
heating up, blazing soon $MGON
I'm in for the long haul... I like their existing operations even without any MJ!!! Add an additional revenue stream and it will be even better! $MGON
25 Employees / Revenues $2.4mil / Profits $585,000
KEEP IN MIND THE ABOVE IS WITH NO MJ! ^^^^^^^^
Now add in MJ and expansion in to US and Canadian markets and we have a real winner.
Also I would love to see an update on their real estate projects and horse breeding.
Multi faceted company here, we only know a little bit of what they have going on!
$MGON 200MIL A/S - 100MIL FLOAT est.
info@acordy.com / www.acordy.com / 25 Employees / Revenues $2.4mil Profits $585,000
________________________________________
TIMELINE
$MGON company is growing like crazy...
Pretax profits for the nine months ending 9-30-2018 came in at €490,524 (approximately USD$ 585,000) representing nearly a 200 % increase over 2017.
MGON big news
CBD $$$$ $CIIX Bounce Play 0.935 -0.055 (-5.56%)
BLAZING $CLDC 1.13 +0.090 (+8.65%)
mmmmmmmmmmmmm YES
$MGON 100m MJ NEWS MERGER COMPLETED!!!
MEGOLA, INC / ACORDY SA (OTC Pink: MGON) COMPLETES RTO (REVERSE TAKEOVER MERGER)
Date : 10/16/2018
Laguna Hills, California, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce the Reverse Take-Over “RTO” of Megola, Inc. and Acordy SA is complete. Acordy SA, formed in 2014 and domiciled in the city of Malaga, Spain, has completed the acquisition of Megola, Inc (MGON) a company registered in the state of Nevada. Acordy President Francisco Baez states: “In the next few weeks we will begin the process of merging Acordy with Megola and Acordy will be the surviving company. We are working with our U.S. attorneys and accountants so as to make the merger as smooth as possible. Going forward, we will be implementing plans with the intent to maximize shareholder value 1) expanding our current products offerings and 2) by leveraging our existing business infrastructure to commercialize CBD products in the next three months. While initially we will be trading on the Pinksheets, we plan on moving up to OTCQB or OTCQX within the next 6-12 months. There is much work to be done, but the first steps have been completed”. John Stippick, former CEO of Megola states, “I am glad to be turning control of Megola to the Acordy team as they are an established company in Europe with impressive financials, an established history, and great plans for the shareholders.”
Management also wants to notify all shareholders and persons of interest to visit http://www.acordyinvest.com for updates and notifications of the company’s original programs and directives.
About Acordy SA.
Acordy S.A. is currently a privately owned Spanish company that was formed in 2014. Acordy has been primarily involved in the production and distribution of food items from Spain with a concentration in olive oils and wines from the Iberian Peninsula. Acordy is also involved with commercial horse breeding. The company is currently planning to become involved in the production and distribution of medical marijuana products and already has the necessary infrastructure in place to commence commercializing CBD products in the next three months.
###
Sections of this press release contain forward looking statements that reflect management’s best judgement based on factors currently known but involve significant risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of a number of factors that will be included in the forthcoming financial statements. Forward looking information provided pursuant to the safe harbor established by recent securities legislation should be evaluated in the context of these factors.
SOURCE Megola, Inc.
RELATED LINKS
http://www.acordyinvest.com
$MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON
MGON Recent CandleStick Analysis
Very Bullish
Date Candle
Oct-15-2018 Hammer
Oct-11-2018 Bullish Engulfing
$MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON
TELLING YOU! DON'T MISS MGON
$MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON
$MGON MERGER TO BE ANNOUNCED THIS WEEK
200MIL A/S - 100MIL FLOAT est.
OLD MANAGEMENT IS NOW GONE.
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=wMbfNq7qXWEUKRQDUFhiEQ%253d%253d&nt7=0
***NEW CEO
William Eric Ottens
More than 25 years experience in executive and financial management with such corporations as Marriott Corporation, Baker-Hughes International, Global Telecom Network and Tekoil and Gas Corporation. Eric attended the University of Maryland where he majored in accounting and finance. Eric was also a helicopter pilot in the U.S. Army and resided for more than 12 years in several South American countries. He is fluent in Spanish, Portuguese and French.
Could one of these be the merge in company?
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=OfficerRegisteredAgentName&inquiryDirectionType=ForwardList&searchNameOrder=OTTENSTRORADUANEL%20P930000021442&SearchTerm=Ottenstroer%2C%20Duane%20L.&entityId=P93000002144&listNameOrder=OTTENSTROERDUANEL%20A208082
https://twitter.com/Room21Media/status/1048090917213589504?s=19
Here's why it will move again... #MGON is currently trading at .0083... Yes way undervalued... #MGON is the process of merging next week.. Yes next week...
$MGON Merger Candidate Checklist: Revenues Financial History Experienced Management ... Official update early next week.
11:02 PM - 4 Oct 2018 from Costa Mesa, CA
https://twitter.com/Room21Media/status/1047348359260852229?s=19
Update $MGON - signed LOI and Term Sheet. DD is being completed! Updates Soon! #Announcement #Updates #Merger $MGON
9:51 PM - 2 Oct 2018 from Dana Point, CA
https://twitter.com/Room21Media/status/1045019617532338176?s=19
We've received several inquiries in regards to Megola, Inc $MGON. It's our obligation to see that the company is once again established with an appropriate enterprise. We are currently solidifying the agreements between a newly identified and MGON leadership.
11:37 AM - 26 Sep 2018 from Laguna Hills, CA
they got anything cooking?
keep a close eye on $MGON
$MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON $MGON MGON
$MPIX court case Monday September 10th.
$NNSR is a long term hold IMO
You think it’s still a buy? NNSR?
$NNSR NOT SURE IF I HAVE EVER SEEN A OTC MERGER THIS BIG...
BIGGEST OTC MERGER EVER???!! GREEN ZEBRA IS NOW $NNSR - CHECK THESE PARTNERS!!!!!!!!!!!
http://greenzebrawifi.com/partners/
the GREEN ZEBRA merger keeps getting better and better! $NNSR
http://wifiadnetwork.com/
more than 100,000 locations and growing daily
http://greenzebramedia.com/guest-wifi-marketing/
Green Zebra Media, Corp. / Year Founded: 2014 / Revenue:$ 17,403,855 / Employees Here:4
Employees Total:100
http://www.buzzfile.com/business/Green-Zebra-Media,-Corp.-949-522-5714
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
Print
Alert
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of retail stores. The retailer collected finger stick blood specimens from 126 customers at their in-store clinics, and shipped the blood cards to Arrayit for processing. Arrayit processed the specimens and reported 126 quantitative total immunoglobulin E (IgE) measurements and 15,120 allergen-specific determinations indicative of food and environmental allergies. The test results were reviewed and approved by the retail chain’s Chief Medical Officer.
Arrayit allergy testing is particularly suitable for large retail chains because convenient finger stick sampling allows customers to integrate a physician-ordered allergy test into their real-time shopping experience. The test results, together with patient symptoms and medical history, enable in-store doctors to make personalized medical recommendations about allergy and asthma treatments and medicines, which are also conveniently provided by the retailer. The retail chain, which reports revenues exceeding $50,000,000,000 ($50 billion US dollars) annually, has more than 2,000 locations nationwide.
Arrayit CEO Rene Schena states, “Completing an allergy testing pilot program for a major retailer advances our clinical initiatives. Arrayit personalized allergy testing, in the context of 1,700 sales reps and a large retail chain, would accelerate our mission to provide health and wellness information to millions of American households.”
$GEVO "Gevo has been producing and selling its patented alcohol-to-jet fuel (ATJ) derived from isobutanol since 2011. Gevo is working toward further commercializing its patented ATJ, which is a clean burning, homegrown, drop-in jet fuel that has the potential to deliver aviation biofuels at scale and at competitive cost. Fossil-based jet fuel is one of the largest expenses for airlines. Gevos ATJ is expected to help reduce the airline industry.s carbon footprint and help control fuel costs."
http://www.gevo.com/our-markets/jet-fuel/
$MJNA Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights - Annual Revenue Increased 230% Over 2016 https://www.medicalmarijuanainc.com/medical-marijuana-inc-reports-fourth-quarter-year-end-2017-financial-results-operational-highlights-annual-revenue-increased-230-2016/
All they need to do is open the Clinics....I have been to 5 of them so I know they exist...
PAOG
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141180385
MGON bottom is in, strong buy
PAOG and RSII conference call in 30 minutes. 3 eastern 2 central time.
Dial in number: 712 775 7035
Access code: 797327
$KNDI vs. $TSLA | Look out Tesla, there's a new kid in town. http://buzz.money.cnn.com/2013/06/17/kandi-tesla-stock/
$RGSE US Solar company. Home Installations
The POWERHOUSETM Solar Shingle is a revolutionary new roofing product that combines the performance and protection of a conventional asphalt
roof with an integrated photovoltaic (PV) system that powers the home.
The POWERHOUSETM Solar Shingle protects the home like a standard roofing shingle while providing energy that saves the homeowner money. Behind a strong brand reputation and warranty, POWERHOUSETM is transforming the residential market by making a solar installation as easy as installing an asphalt rooftop – all while maintaining the home’s attractiveness.
RGS Energy can now serve the need of homeowners who want to go solar, but aren’t willing to accept the complexity and sub-optimal aesthetics currently offered by
bulky, rack-mounted systems.
The POWERHOUSETM 3.0 Solar Shingles Product Details
The POWERHOUSETM Solar Shingles are engineered to address the historical un-met needs of the residential homeowners by functioning differently from any other product available to homeowners with asphalt rooftops – which represent approximately 85 percent of U.S. homes. It operates as both a roof and solar product, and is installed directly onto the roof deck along with standard asphalt roofing shingles.
POWERHOUSETM Solar Shingles are both the roof and the solar energy generator, and look like they actually belong on a home. POWERHOUSETM is based upon technology developed by The Dow Chemical Company leading the introduction of POWERHOUSETM 1.0 and 2.0 to the solar community. POWERHOUSETM 3.0 is designed to address the critical customer and requirements and achieves a price point that will be very competitive.
https://rgspowerhouse.com/
Nrpi getting action yesterday
$KNDI vs. $TSLA | Look out Tesla, there's a new kid in town. http://buzz.money.cnn.com/2013/06/17/kandi-tesla-stock/
Would have been a great buy at 6.50
Your all over the place, lol
$RGSE Next Generation POWERHOUSE™ 3.0
By coupling roofing with an energy saving solar panel in a singular product, the POWERHOUSE™ Solar Shingle uniquely addresses the needs of residential homeowners that seek an affordable visually stunning solar option. POWERHOUSE™ is designed to work with asphalt roofs, which represent about 85 percent of U.S. homes. Currently, more than 1,000 homeowners are enjoying benefits of earlier generations of POWERHOUSE™.
RGS Energy believes POWERHOUSE™ addresses a large, untapped market, appealing to both single-family homeowners and new home builders. The forthcoming POWERHOUSE™ 3.0 is designed to maintain or improve upon earlier generation product features, while substantially reducing manufacturing costs. POWERHOUSE™ 3.0 will offer a more competitive value proposition, even after the recently imposed tariff on imported solar cells.
RGS Energy estimates if POWERHOUSE™ achieves a 1% share of the re-roof and new home build markets, the product could be propelled to the billion-dollar revenue mark.
$INSY BOUNCE PLAY 6.71-0.24 (-3.45%)
Followers
|
176
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6383
|
Created
|
03/28/14
|
Type
|
Free
|
Moderator JohnnyBlaze | |||
Assistants |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |